HK1074635A1 - Lactoferrin - Google Patents

Lactoferrin

Info

Publication number: HK1074635A1
Authority: HK; Hong Kong
Prior art keywords: lactoferrin
Prior art date: 2002-04-03

Application number

HK05108745.6A

Other languages

English (en)

Inventor

Jillian Cornish

Ian Reginald Reid

Kay Patricia Palmano

Neill Ward Haggarty

Original Assignee

Fonterra Res Ct Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-03

Filing date

2005-09-30

Publication date

2005-11-18

2005-09-30 Application filed by Fonterra Res Ct Ltd filed Critical Fonterra Res Ct Ltd

2005-11-18 Publication of HK1074635A1 publication Critical patent/HK1074635A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Orthopedic Medicine & Surgery (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Peptides Or Proteins (AREA)

HK05108745.6A 2002-04-03 2005-09-30 Lactoferrin HK1074635A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ51812102		2002-04-03
PCT/NZ2002/000137 WO2003082921A1 (en)	2002-04-03	2002-07-29	Lactoferrin

Publications (1)

Publication Number	Publication Date
HK1074635A1 true HK1074635A1 (en)	2005-11-18

Family

ID=28673156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK05108745.6A HK1074635A1 (en)	2002-04-03	2005-09-30	Lactoferrin

Country Status (14)

Country	Link
US (5)	US20030191193A1 (xx)
EP (1)	EP1490404B1 (xx)
JP (1)	JP4327607B2 (xx)
KR (1)	KR20050006140A (xx)
CN (1)	CN1625566B (xx)
AR (1)	AR040695A1 (xx)
AU (1)	AU2002324387A1 (xx)
BR (1)	BR0215682A (xx)
CA (1)	CA2481315A1 (xx)
DK (1)	DK1490404T3 (xx)
ES (1)	ES2435071T3 (xx)
HK (1)	HK1074635A1 (xx)
PT (1)	PT1490404E (xx)
WO (1)	WO2003082921A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030191193A1 (en) *	2002-04-03	2003-10-09	Jillian Cornish	Lactoferrin
NZ536338A (en) *	2002-11-29	2006-04-28	Morinaga Milk Industry Co Ltd	Lactoferrin as a cysteine protease inhibitor
US7956031B2 (en)	2005-05-31	2011-06-07	Naidu Lp	Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
TWI276442B (en) *	2005-07-05	2007-03-21	Maxluck Biotechnology Corp	Composition of controlling and preventing heart disease
EP1937298A4 (en) *	2005-10-14	2009-11-11	Auckland Uniservices Ltd	USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
US20090130191A1 (en) *	2005-10-27	2009-05-21	Sunstar Inc.	Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin
US8021659B2 (en)	2006-04-28	2011-09-20	Naidu Lp	Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
FR2903906B1 (fr) *	2006-07-19	2010-11-05	Bio Serae Laboratoires	Composition pour prevenir et/ou traiter les maladies articulaires degeneratives.
WO2008094493A2 (en) *	2007-01-26	2008-08-07	Ventria Bioscience	Compositions containing lactoferrin and calcium, and methods of using same
JP2008303168A (ja) *	2007-06-07	2008-12-18	Japan Health Science Foundation	破骨細胞制御剤とそのスクリーニング方法
ES2518290T3 (es)	2007-07-10	2014-11-04	Glanbia Nutritionals (Ireland) Limited	Método de eliminación de endotoxinas de proteínas
US8614189B2 (en) *	2008-09-24	2013-12-24	University Of Connecticut	Carbon nanotube composite scaffolds for bone tissue engineering
MX2011005527A (es)	2008-11-28	2011-09-28	Univ Otago	Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
FR2950510B1 (fr) *	2009-09-28	2013-04-12	Groupe Lactalis	Derive laitier pour son utilisation dans le developpement et/ou le maintien de la condition physique des mammiferes, en particulier des animaux de competition.
US8545927B2 (en)	2010-05-10	2013-10-01	University Of Connecticut	Lactoferrin-based biomaterials for tissue regeneration and drug delivery
WO2015000694A1 (en) *	2013-07-05	2015-01-08	Nestec S.A.	Lactoferrin-osteopontin-iron complex
US10018418B2 (en)	2014-01-07	2018-07-10	Can-Eng Partners Limited	Mobile removable hearth for furnace and transporter
EP4136985A1 (en)	2016-12-22	2023-02-22	University of Otago	Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12019501439B1 (en)	2016-12-22	2024-02-23	Univ Of Otago	Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US154032A (en) *		1874-08-11		Improvement in processes of preparing glass
US4073A (en) *		1845-06-07		Machine fob
FR884786A (fr) *	1942-04-03	1943-08-26	Comp Generale Electricite	Sortie isolante pour câble électrique soumis à de hautes pressions
JPH0621077B2 (ja) *	1986-07-15	1994-03-23	雪印乳業株式会社	造血剤
JP2564185B2 (ja) *	1988-10-11	1996-12-18	森永乳業株式会社	生物活性組成物
EP0389795B1 (en) *	1989-02-25	1993-06-23	Morinaga Milk Industry Co., Ltd.	Bioactive lactoferrin derivates
EP0426924A1 (en)	1989-11-09	1991-05-15	Cellena (Cell Engineering) A.G.	Production of metal transporter compositions for facilitating the engraftment of histo-incompatible bone marrow and controlling the immune reactions in the recipient host
US5240909B1 (en) *	1990-03-14	1998-01-20	Dietrich Nitsche	Use of lactoferrin for treatment of toxic effects of endotoxins
ATE129125T1 (de) *	1992-01-15	1995-11-15	Campina Melkunie Bv	Verfahren zur isolierung von lactoferrin und lactoperoxidase aus milch und milchprodukten.
JP3100005B2 (ja) *	1992-07-28	2000-10-16	雪印乳業株式会社	ヒト免疫不全ウィルス感染・増殖抑制剤
JP3112637B2 (ja) *	1994-09-30	2000-11-27	雪印乳業株式会社	骨強化剤
JP2974604B2 (ja)	1996-01-23	1999-11-10	雪印乳業株式会社	塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
EP0920331A1 (en) *	1996-08-12	1999-06-09	A+ Science Invest AB	Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
JPH1059864A (ja) *	1996-08-15	1998-03-03	Morinaga Milk Ind Co Ltd	経口がん転移抑制剤
US6440446B1 (en) *	1998-04-22	2002-08-27	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Agent for anti-osteoporosis
US6251860B1 (en) *	1998-07-07	2001-06-26	Suomen Punainen Risti Veripalvelu	Pharmaceutical preparations
EP1116490A4 (en) *	1998-07-30	2004-08-04	Morinaga Milk Industry Co Ltd	LIVER FUNCTION IMPROVING AGENTS
CA2279791C (en) *	1998-08-14	2011-11-08	Marcus B. Gohlke	Dietary supplement combining colostrum and lactorferrin in a mucosal delivery format
JP3739589B2 (ja) *	1999-03-31	2006-01-25	雪印乳業株式会社	骨強化剤
US6251560B1 (en) *	2000-05-05	2001-06-26	International Business Machines Corporation	Photoresist compositions with cyclic olefin polymers having lactone moiety
AU2002230997A1 (en) *	2000-12-15	2002-06-24	Genetics Institute, Llc	Methods and compositions for diagnosing and treating rheumatoid arthritis
US20030191193A1 (en) *	2002-04-03	2003-10-09	Jillian Cornish	Lactoferrin

2002
- 2002-07-26 US US10/205,960 patent/US20030191193A1/en not_active Abandoned
- 2002-07-29 KR KR10-2004-7015712A patent/KR20050006140A/ko not_active Application Discontinuation
- 2002-07-29 AU AU2002324387A patent/AU2002324387A1/en not_active Abandoned
- 2002-07-29 CN CN028288009A patent/CN1625566B/zh not_active Expired - Fee Related
- 2002-07-29 WO PCT/NZ2002/000137 patent/WO2003082921A1/en active Application Filing
- 2002-07-29 BR BR0215682-2A patent/BR0215682A/pt not_active IP Right Cessation
- 2002-07-29 ES ES02758971T patent/ES2435071T3/es not_active Expired - Lifetime
- 2002-07-29 PT PT27589712T patent/PT1490404E/pt unknown
- 2002-07-29 JP JP2003580384A patent/JP4327607B2/ja not_active Expired - Fee Related
- 2002-07-29 CA CA002481315A patent/CA2481315A1/en not_active Abandoned
- 2002-07-29 DK DK02758971.2T patent/DK1490404T3/da active
- 2002-07-29 EP EP02758971.2A patent/EP1490404B1/en not_active Expired - Lifetime
2003
- 2003-07-25 AR AR20030102683A patent/AR040695A1/es not_active Application Discontinuation
2005
- 2005-09-30 HK HK05108745.6A patent/HK1074635A1/xx not_active IP Right Cessation
2008
- 2008-04-04 US US12/098,253 patent/US20080188644A1/en not_active Abandoned
2009
- 2009-06-29 US US12/493,919 patent/US20090259025A1/en not_active Abandoned
2010
- 2010-08-09 US US12/853,149 patent/US20100305308A1/en not_active Abandoned
2011
- 2011-04-07 US US13/082,334 patent/US8703699B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1490404A4 (en)	2010-02-24
US20030191193A1 (en)	2003-10-09
CN1625566A (zh)	2005-06-08
US8703699B2 (en)	2014-04-22
CA2481315A1 (en)	2003-10-09
AR040695A1 (es)	2005-04-13
CN1625566B (zh)	2012-10-10
US20090259025A1 (en)	2009-10-15
JP4327607B2 (ja)	2009-09-09
PT1490404E (pt)	2013-09-24
EP1490404B1 (en)	2013-08-21
WO2003082921A1 (en)	2003-10-09
ES2435071T3 (es)	2013-12-18
US20110183008A1 (en)	2011-07-28
EP1490404A1 (en)	2004-12-29
JP2006501143A (ja)	2006-01-12
US20080188644A1 (en)	2008-08-07
BR0215682A (pt)	2005-01-04
AU2002324387A1 (en)	2003-10-13
DK1490404T3 (da)	2013-09-16
US20100305308A1 (en)	2010-12-02
KR20050006140A (ko)	2005-01-15

Publication	Publication Date	Title
HK1074635A1 (en)	2005-11-18	Lactoferrin
GB0208089D0 (en)	2002-05-22	Protein
GB0201808D0 (en)	2002-03-13	Protein
AU2003278718A8 (en)	2004-03-11	Stars-a muscle-specification-binding protein
GB0213964D0 (en)	2002-07-31	Protein
GB0204735D0 (en)	2002-04-17	Protein
GB0202748D0 (en)	2002-03-27	Protein
GB0209621D0 (en)	2002-06-05	Protein
GB0209157D0 (en)	2002-05-29	Protein
GB0209488D0 (en)	2002-06-05	Protein
GB0208278D0 (en)	2002-05-22	Protein
GB0205268D0 (en)	2002-04-17	Protein
GB0203163D0 (en)	2002-03-27	Protein
GB0210140D0 (en)	2002-06-12	Protein
GB0203161D0 (en)	2002-03-27	Protein
GB0205264D0 (en)	2002-04-17	Protein
GB0208091D0 (en)	2002-05-22	Protein
GB0203159D0 (en)	2002-03-27	Protein
GB0210141D0 (en)	2002-06-12	Protein
GB0211671D0 (en)	2002-07-03	Protein
GB0211830D0 (en)	2002-07-03	Protein
GB0212185D0 (en)	2002-07-03	Protein
GB0203158D0 (en)	2002-03-27	Protein
GB0203165D0 (en)	2002-03-27	Protein
GB0203157D0 (en)	2002-03-27	Protein

Legal Events

Date	Code	Title	Description
2017-02-24	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20160729